Author Title Type [ Year(Desc)]
Filters: Author is Arora, Mukta  [Clear All Filters]
Hegerova, L., Bachan, A., Cao, Q., Vu, H.X., Rogosheske, J., Reding, M.T., Brunstein, C.G., Arora, M., Ustun, C., Vercellotti, G.M., et al. (2018). Catheter-related Thrombosis in Patients with Lymphoma or Myeloma Undergoing Autologous Stem Cell Transplantation.Biol Blood Marrow Transplant.
Chhabra, S., Liu, Y., Hemmer, M.T., Costa, L., Pidala, J.A., Couriel, D.R., Alousi, A.M., Majhail, N.S., Stuart, R.K., Kim, D., et al. (2018). Comparative analysis of calcineurin-inhibitor-based methotrexate and mycophenolate mofetil-containing regimens for prevention of Graft-versus-Host Disease after reduced intensity conditioning allogeneic transplantation.Biol Blood Marrow Transplant.
Alousi, A., Wang, T., Hemmer, M.T., Spellman, S.R., Arora, M., Couriel, D.R., Pidala, J., Anderlini, P.N., Boyiadzis, M., Bredeson, C.N., et al. (2018). Peripheral Blood versus Bone Marrow from Unrelated Donors: Bone Marrow allografts have improved Long-term Overall and Graft-versus-Host Disease, Relapse-Free Survival.Biol Blood Marrow Transplant.
Turcotte, L.M., Wang, T., Hemmer, M.T., Spellman, S.R., Arora, M., Yingst, A., Couriel, D., Alousi, A., Pidala, J., Knight, J.M., et al. (2018). Pro-inflammatory Cytokine and Adipokine Levels in Adult Unrelated Marrow Donors Are Not Associated with Hematopoietic Cell Transplantation Outcomes.Biol Blood Marrow Transplant.
Warlick, E.Dahl, DeFor, T.E., Bejanyan, N., Holtan, S., MacMillan, M., Blazar, B.R., Dusenbery, K., Arora, M., Bachanova, V., Cooley, S., et al. (2018). Reduced Intensity Conditioning Followed by Related and Unrelated Allografts for Hematologic Malignancies: Expanded Analysis and Long Term Follow-Up.Biol Blood Marrow Transplant.